Neurofeedback training shows no benefit for attention and inhibition in adults with ADHD
This randomized controlled trial evaluated neurofeedback (NFB) training versus a waitlist control in 44 adults with ADHD (NFB group n=23; waitlist group n=21). The study did not report a primary outcome and was a secondary analysis. Assessments were conducted before and after the NFB training period.
The main analyses focused on TOVA behavioral performance and neural indices, including event-related potentials and power spectral density. The investigators reported no meaningful evidence for NFB-specific improvements in TOVA performance over time. They also found no evidence that NFB modulated event-related potentials or spectral indices relative to the ADHD-W group.
No adverse events, serious adverse events, discontinuations, or tolerability data were reported. Key limitations include the absence of a prespecified primary outcome, a small sample size, and the use of secondary analyses. Bayesian linear mixed models were used, but no effect sizes or confidence intervals were reported.
Given these limitations, the study does not demonstrate causal efficacy for NFB treatment. The practice relevance is limited, as there was no evidence that NFB meaningfully benefits sustained attention or inhibitory control in this adult ADHD population.